PMU9 Budget Impact Analysis of Expanding Use of Recombinant Human Hyaluronidase-facilitated Subcutaneous Ig Infusion in patients with Primary Immunodeficiencies (PID) in Brazil
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.721
https://www.valueinhealthjournal.com/article/S1098-3015(21)00938-4/fulltext
Title :
PMU9 Budget Impact Analysis of Expanding Use of Recombinant Human Hyaluronidase-facilitated Subcutaneous Ig Infusion in patients with Primary Immunodeficiencies (PID) in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00938-4&doi=10.1016/j.jval.2021.04.721
First page :
Section Title :
Open access? :
No
Section Order :
10230